Fundraising FoxNEURALTIDE
Paris, FR · 1 known investors
Find your way into NEURALTIDE
Sign up to see every warm intro you have to NEURALTIDE
- Paths you didn't know you had: your email and LinkedIn already hold routes to the NEURALTIDE team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Neuraltide develops the Swell-Suit, a non-invasive medical device based on the lower-body positive-pressure principle that improves cerebral perfusion to treat ischemic stroke patients. It aims to extend the therapeutic window up to 24 hours for patients who are not eligible for standard revascularisation treatment.
Founders & leadership
Investors · 1
Frequently asked questions
- What does NEURALTIDE do?
- Neuraltide develops the Swell-Suit, a non-invasive medical device based on the lower-body positive-pressure principle that improves cerebral perfusion to treat ischemic stroke patients. It aims to extend the therapeutic window up to 24 hours for patients who are not eligible for standard revascularisation treatment.
- Who founded NEURALTIDE?
- NEURALTIDE was founded by Karine Berthet.
- Who are NEURALTIDE's investors?
- NEURALTIDE's investors include Agoranov.
- Where is NEURALTIDE headquartered?
- NEURALTIDE is headquartered in Paris, FR.